Darwich, A
, Aarons, L, Galetin, A, Rostami-Hochaghan et al, A, Margolskee, A, Pepin, X, Carlert, S, Hammarberg, M, Hilgendorf, C, Johansson, P, Karlsson, E, Murphy, D, Tannergren, C, Thorn, H, Yasin, M, Mazuir, F, Nicolas, O, Ramusovic, S, Xu, C, Pathak, S, Korjamo, T, Laru, J, Malkki, J, Pappinen, S, Tuunainen, J, Dressman, J, Hansmann, S, Kostewicz, ES, He, H, Heimbach, T, Wu, F, Hoft, C, Pang, Y, Bolger, M, Huehn, E, Heimbach, T, Wu, F, Hoft, C, Pang, Y, Bolger, MB, Huehn, E, Lukacova, V, Mullin, JM, Szeto, KX, Costales, C, Lin, J, McAllister, M, Modi, S, Rotter, C, Varma, M, Wong, M, Mitra, A, Bevernage, J, Biewenga, J, Peer, AV, Lloyd, R, Shardlow, C, Langguth, P, Mishenzon, I, Nguyen, MA, Brown, J, Lennerans, H & Abrahmsson, B 2017, '
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes',
European Journal of Pharmaceutical Sciences, vol. 96, pp. 626-642.
https://doi.org/10.1016/j.ejps.2016.09.037